Pharmacological evaluation of 1229U91, a novel high-affinity and selective neuropeptide Y-Y1 receptor antagonist

Journal of Pharmacology and Experimental Therapeutics

Volumn 275, Issue 3, 1995, Pages 1261-1266

  Hegde, S S ^a   Bonhaus, D W ^a   Stanley, W ^a   Eglen, R M ^a   Moy, T M ^a   Loeb, M ^a   Shetty, S G ^a   Desouza, A ^a   Krstenansky, J ^a  

^a ROCHE BIOSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; GR 231118; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NORADRENALIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROENDOCRINOLOGY; NEUROTRANSMISSION; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

AMINO ACID SEQUENCE; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CELL LINE; DECEREBRATE STATE; IODINE RADIOISOTOPES; KIDNEY; MALE; MOLECULAR SEQUENCE DATA; NEUROPEPTIDE Y; NOREPINEPHRINE; PEPTIDES, CYCLIC; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; VAS DEFERENS;

EID: 0029552033     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)